CA2104372A1 - Stable salts of (+)-(1s,2r)-2-¬¬n-(2-hydroxylamino-2-oxoethyl) -n-methyl-amino|carbonyl|cyclohexane-1-carboxylic acid, pro ess for their preparation and pharmaceutical compositions containing them - Google Patents

Stable salts of (+)-(1s,2r)-2-¬¬n-(2-hydroxylamino-2-oxoethyl) -n-methyl-amino|carbonyl|cyclohexane-1-carboxylic acid, pro ess for their preparation and pharmaceutical compositions containing them

Info

Publication number
CA2104372A1
CA2104372A1 CA002104372A CA2104372A CA2104372A1 CA 2104372 A1 CA2104372 A1 CA 2104372A1 CA 002104372 A CA002104372 A CA 002104372A CA 2104372 A CA2104372 A CA 2104372A CA 2104372 A1 CA2104372 A1 CA 2104372A1
Authority
CA
Canada
Prior art keywords
oxoethyl
carbonyl
carboxylic acid
alkaline
hydroxylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002104372A
Other languages
English (en)
French (fr)
Inventor
Raffaello Giorgi
Alessandro Subissi
Luigi Turbanti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Guidotti SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2104372A1 publication Critical patent/CA2104372A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA002104372A 1991-12-23 1992-12-12 Stable salts of (+)-(1s,2r)-2-¬¬n-(2-hydroxylamino-2-oxoethyl) -n-methyl-amino|carbonyl|cyclohexane-1-carboxylic acid, pro ess for their preparation and pharmaceutical compositions containing them Abandoned CA2104372A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI91A003448 1991-12-23
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Publications (1)

Publication Number Publication Date
CA2104372A1 true CA2104372A1 (en) 1993-06-24

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002104372A Abandoned CA2104372A1 (en) 1991-12-23 1992-12-12 Stable salts of (+)-(1s,2r)-2-¬¬n-(2-hydroxylamino-2-oxoethyl) -n-methyl-amino|carbonyl|cyclohexane-1-carboxylic acid, pro ess for their preparation and pharmaceutical compositions containing them

Country Status (26)

Country Link
EP (1) EP0575572A1 (pt)
JP (1) JPH06506002A (pt)
CN (1) CN1079474A (pt)
AU (1) AU657591B2 (pt)
BG (1) BG98050A (pt)
BR (1) BR9205652A (pt)
CA (1) CA2104372A1 (pt)
CZ (1) CZ379692A3 (pt)
EE (1) EE9400006A (pt)
FI (1) FI933685A0 (pt)
HR (1) HRP921454A2 (pt)
HU (1) HUT69287A (pt)
IT (1) IT1252708B (pt)
LV (1) LV10426B (pt)
MA (1) MA22749A1 (pt)
MX (1) MX9207543A (pt)
NZ (1) NZ245547A (pt)
PL (1) PL169086B1 (pt)
PT (1) PT101156A (pt)
RU (1) RU2079489C1 (pt)
SI (1) SI9200409A (pt)
SK (1) SK379692A3 (pt)
TN (1) TNSN92117A1 (pt)
WO (1) WO1993013056A1 (pt)
YU (1) YU110892A (pt)
ZA (1) ZA9210004B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
CN101516191A (zh) * 2006-09-28 2009-08-26 默克公司 Saha的胺碱盐和其多晶型物
CN114845603B (zh) 2020-04-27 2025-01-24 卡特-霍夫曼有限责任公司 用于柜的门移动系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
JPH06506002A (ja) 1994-07-07
MX9207543A (es) 1993-08-01
AU657591B2 (en) 1995-03-16
AU3087192A (en) 1993-07-28
SI9200409A (en) 1993-09-30
CN1079474A (zh) 1993-12-15
ITMI913448A1 (it) 1993-06-23
RU2079489C1 (ru) 1997-05-20
MA22749A1 (fr) 1993-07-01
NZ245547A (en) 1995-12-21
LV10426B (en) 1995-08-20
FI933685L (fi) 1993-08-20
FI933685A7 (fi) 1993-08-20
EP0575572A1 (en) 1993-12-29
ZA9210004B (en) 1993-12-13
PL297118A1 (en) 1993-09-06
HU9302389D0 (en) 1993-11-29
PT101156A (pt) 1994-06-30
SK379692A3 (en) 1995-04-12
FI933685A0 (fi) 1993-08-20
ITMI913448A0 (it) 1991-12-23
BG98050A (bg) 1994-04-29
BR9205652A (pt) 1994-05-03
HRP921454A2 (en) 1995-02-28
WO1993013056A1 (en) 1993-07-08
LV10426A (lv) 1995-02-20
EE9400006A (et) 1995-12-15
CZ379692A3 (en) 1993-09-15
HUT69287A (en) 1995-09-28
IT1252708B (it) 1995-06-26
YU110892A (sh) 1996-01-08
PL169086B1 (pl) 1996-05-31
TNSN92117A1 (fr) 1993-06-08

Similar Documents

Publication Publication Date Title
US7790743B2 (en) Modulators of cellular adhesion
KR100388747B1 (ko) 인돌유도체
JPH02104526A (ja) 高血圧症治療用組成物
JP2001502296A (ja) ニューロペプチド―yリガンド
NZ222825A (en) Pyridazodiazepine derivatives and pharmaceutical compositions
IE841782L (en) Peptides
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
SI21236A (sl) Postopek kristalizacije losartan kalija
US4734501A (en) N-alkylation of dihydrolysergic acid
AU657591B2 (en) Stable salts of (+)-(1S,2R)-2-((N-(2-hydroxylamino-2-oxoethyl)-N-methyl- amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them
JPS63297377A (ja) 新規アミノ酸基含有4‐ベンジル‐1‐(2h)‐フタラジノン誘導体、その製法、及び該化合物を含有する抗ぜんそく及び抗アレルギー作用を有する医薬品
EP0134582A2 (en) Novel peptides and process for preparing the same and pharmaceutical composition
US4490386A (en) Phosphate salts of 1-[2-[(1-alkoxycarbonyl-3-aralkyl)-amino]-1-oxoalkyl]octahydro-1H-indole-2-carboxylic acids, preparation of, and medical compositions thereof
EP0193965A2 (en) Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them
KR880002594B1 (ko) 트리펲타이드를 함유한 n-카르복시알킬프롤린을 제조하는 방법
CA1199638A (en) Eburnane-oxime ethers, process for their preparation and pharmaceutical compositions containing them
US4370494A (en) Converting enzyme inhibitors
WO1995004043A1 (en) Optical resolution of gamma-(4-(((1,1-dimethylethoxy)carbonyl)methylamino)-piperidinyl-1)-gamma-oxo-alpha-(phenylmethyl)-butynic acid with (n,s-)cyclohexyl ethylamine
EP0170549B1 (fr) Dérivés de tétrahydro-4,5,6,7 furo ou 1H-pyrrolo[2,3-c]pyridine, leur préparation et leur application en therapeutique
US4113877A (en) Substituted 2-aminomethylphenyl sulfamates
US5099022A (en) Process for purification of 1,2-bis(nicotinamido)propane
EP0213571A2 (de) 3-Aminomethylpyrrol-1-yl-alkylamine und diese Verbindungen enthaltende therapeutische Mittel
EP0101633A1 (en) Pyridinecarboxylic esters of dopamine and of its N-alkyl derivatives
RU2109742C1 (ru) Гидроксиламины и способ их получения
EP0333073A2 (en) N-cycloalkylaminoethylbenzamide derivatives, their synthesis and pharmaceutical preparations

Legal Events

Date Code Title Description
FZDE Discontinued